Histone Deacetylase Inhibitors as Cancer Therapeutics

Annals of Translational Medicine - China
doi 10.21037/atm.2016.07.22
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

AME Publishing Company

Related search

Development of Histone Deacetylase Inhibitors as Therapeutics for Neurological Disease

Future Neurology
Neurology
2009English

Histone Deacetylase Inhibitors in Cancer Therapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Inhibitors of Histone-Deacetylase

Journal of Applied Biomedicine
GeneticsMolecular BiologyPharmacologyBiochemistryBiological SciencesToxicologyMedicineAgriculturalNeurosciencePharmaceutics
2005English

Thioredoxin in Cancer—Role of Histone Deacetylase Inhibitors

Seminars in Cancer Biology
Cancer Research
2006English

Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells

Cancers
Cancer ResearchOncology
2019English

Pharmacogenomics and Histone Deacetylase Inhibitors

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2016English

Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties

2011English

Histone Deacetylase Inhibitors From Burkholderia Thailandensis

Journal of Natural Products
Organic ChemistryMolecular MedicinePharmacologyComplementaryPharmaceutical ScienceAnalytical ChemistryAlternative MedicineDrug Discovery
2011English

Selectively Targeting Prostate Cancer With Antiandrogen Equipped Histone Deacetylase Inhibitors

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy